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Although hemin-mediated neurotoxicity has been linked to the production of free radicals
and glutamate excitotoxicity, the role of the prostaglandin E2 (PGE2)-EP1 receptor remains
unclear. Activation of the EP1 receptor in neurons results in increased intracellular calcium
levels; therefore, we hypothesize that the blockade of the EP1 receptor reduces hemin
neurotoxicity. Using postnatal primary cortical neurons cultured from wild-type (WT) and
EP1−/− mice, we investigated the EP1 receptor role in hemin neurotoxicity measured
by lactate dehydrogenase (LDH) cell survival assay. Hemin (75μM) induced greater
release of LDH in WT (34.7 ± 4.5%) than in EP1−/− (27.6 ± 3.3%) neurons. In the
presence of the EP1 receptor antagonist SC-51089, the hemin-induced release of LDH
decreased. To further investigate potential mechanisms of action, we measured changes
in the intracellular calcium level [Ca2+]i following treatment with 17-phenyl trinor PGE2
(17-pt-PGE2) a selective EP1 agonist. In the WT neurons, 17-pt-PGE2 dose-dependently
increased [Ca2+]i. However, in EP1−/− neurons, [Ca2+]i was significantly attenuated.
We also revealed that hemin dose-dependently increased [Ca2+]i in WT neurons, with a
significant decrease in EP1−/− neurons. Both 17-pt-PGE 22 and hemin-induced [Ca +]i were
abolished by N-methyl-D-aspartic (NMDA) acid receptor and ryanodine receptor blockers.
These results suggest that blockade of the EP1 receptor may be protective against
hemin neurotoxicity in vitro. We speculate that the mechanism of hemin neuronal death
involves [Ca2+]i mediated by NMDA acid receptor-mediated extracellular Ca2+ influx and
EP1 receptor-mediated intracellular release from ryanodine receptor-operated Ca2+ stores.
Therefore, blockade of the EP1 receptor could be used to minimize neuronal damage
following exposure to supraphysiological levels of hemin.
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INTRODUCTION
Heme is a protein prosthetic group consisting of a porphyrin ring
and an iron atom in the center (Padmanaban et al., 1989). Heme
is most commonly recognized as vital component of hemoglobin
(Hb). The mitochondria are the main site for heme synthesis,
and heme is essential for mitochondrial function. After its syn-
thesis in the mitochondria, heme can migrate across lipid-water
interfaces and hence diffuse rapidly from the mitochondrial inner
membrane (site of synthesis) to the rough endoplasmic reticulum
where it is incorporated into Hb. Under physiological conditions,
free heme is rarely detected. In hemoproteins, heme is bound to
aromatic amino acid, such as phenylalanine, tyrosine, or trypto-
phan, allowing for its hydrophobic properties (Li et al., 2011).
Also, under normal physiological conditions, the bond between
heme and Hb is very stable; hence, the amount of free heme
is expected to be negligible. However, in aged or pathological
cells, Hb becomes oxidized and denatured, weakening the bond
between heme and Hb; thus the cellular effects of free heme are
increased (Shaklai et al., 1985). Under pathophysiological con-
ditions high concentrations of free heme can also enter cells by
heme-transporters (Krishnamurthy and Schuetz, 2005; Azuma
et al., 2008).
The biological function of heme stems from the iron atom
bound in the central porphyrin ring of the molecule. Iron is
redox-active and can readily accept or donate electrons, i.e., fer-
rous iron (Fe2+) is oxidized to ferric iron (Fe3+). However, under
pathophysiological conditions, disruptions in iron homeostasis
can cause an increase in the oxidation of iron from Fe2+ to Fe3+
via the Fenton reaction. The increase in Fe3+ concentration can
produce harmful superoxide free radicals in the brain that lead to
oxidative stress and neuronal death (Smith and Perry, 1995; Valko
et al., 2005). Hemolysis of erythrocytes releases Hb into the extra-
cellular space and becomes oxidized from ferrous to ferric Hb,
which in turn causes the release of heme (Umbreit, 2007). When
internalized by cells, free heme is catabolized by heme oxygenases
(HO1 and HO2 isoforms) into hemin (Balla et al., 1993; Ferris
et al., 1999). HO2 is constitutively expressed and catabolizes heme
at homeostatic conditions (Trakshel et al., 1986). However, excess
heme induces the expression of the stress-responsive HO1 iso-
form, which results in increased heme breakdown, and under
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physiological conditions, prevents its putative neurotoxic effects
(Ferris et al., 1999; Wang and Doré, 2007; Gozzelino et al.,
2010). Similarly, when activated under physiological conditions,
the HO2 isoform converts hemin to iron, biliverdin and bilirubin
which have been found to be neuroprotective against oxidative
stress (Doré et al., 1999). Supraphysiological levels of hemin
are neurotoxic due to its ability to contribute to the produc-
tion of reactive oxygen species (ROS) which are mediated by the
redox iron (Kumar and Bandyopadhyay, 2005). Hemin can also
cause endothelial injury and has pro-inflammatory properties
that create pathology in multiple diseases. For example, hemin
released from lyzed erythrocytes can contribute to brain damage
as seen after hemorrhagic stroke (Regan et al., 2001, 2002, 2004;
Goldstein et al., 2003).
Recent evidences suggest that the accumulation of intact
hemin itself is more neurotoxic than the iron released from
its breakdown (Dang et al., 2011). Here, we present data that
may provide further evidence for the basis of hemin-mediated
neurotoxicity. In addition, a recent study provided evidence for
iron accumulation mediated by inflammatory stimuli in neu-
rons and microglia, suggesting that neuroinflammation results
in intracellular iron accumulation and oxidative damage (Urrutia
et al., 2013). Therefore, further studies on the cross-talk between
neuroinflammatory mediators such as prostaglandins and iron-
containing hemoproteins or hemin are warranted.
Prostaglandins, via their specific G protein coupled receptors,
have a variety of physiological functions in the central nervous
system. Themajor prostaglandin, prostaglandin E2 (PGE2) is pro-
duced by various cell types and is involved in ischemic neuronal
injury (Doré et al., 2003; Li et al., 2008). We and others have
found that targeting different types of prostaglandin receptors by
selective blockade or activation protects against neurotoxicity and
ischemic stroke (Echeverria et al., 2005; Ahmad et al., 2006a,b;
Doré, 2006). The up-regulation of cyclooxygenase-2 (COX-2) and
greater PGE2 levels together contribute to N-methyl-D-aspartic
acid (NMDA)-induced neuronal injury (Hewett et al., 2000;
Ahmad et al., 2006a, 2008). Activation of these PGE2 receptors
can regulate intracellular levels of cyclic adenosine monophos-
phate and/or calcium ([Ca2+]i) (Kim et al., 2002; Linhart et al.,
2003). The effects of PGE2 are regulated by its respective affin-
ity for its receptors and their relative abundance, which we
recently reviewed (Mohan et al., 2012). Although the neuro-
toxicity of hemin has been previously demonstrated, the role
of prostaglandins and their cognate receptors in hemin-induced
neurotoxicity remains not fully understood. Using in vivo and
in vitro experiments, activation of the EP1 receptor has been
reported to be consistently involved in PGE2-mediated neurotox-
icity (Lee et al., 2004; Carrasco et al., 2007; Ahmad et al., 2008).
We present here functional data that supports previous reports
on the role of the EP1 receptor in neurotoxicity. Using genetic
and pharmacological tools, we hypothesize that EP1 receptor-
mediated signaling potentiates hemin-mediated cytotoxicity in
cortical neurons. We first investigated expression of EP1 and
other PGE2 receptor subtypes in primary cultured cortical neu-
rons. Next, we determined what concentration of hemin would
produce neurotoxicity and we addressed the importance of the
EP1 receptor. Then, to elucidate functional changes we measured
changes in Ca2+ signaling in response to the EP1 receptor agonist,
17-pt-PGE2 and hemin with and without the pharmacological
blockers used to determine the source of calcium. This is the first
known study to measure the effect of EP1 receptor in hemin-
mediated neurotoxicity and [Ca2+]i in primary cortical neuronal
culture.
MATERIALS AND METHODS
All animal protocols were approved by the Institutional Animal
Care and Use Committee of the University of Florida. All mice
were maintained and housed in the University’s core facilities
under controlled conditions with ad libitum access to food and
water.
PREPARATION OF POSTNATAL PRIMARY CORTICAL NEURONAL
CULTURES
Postnatal mouse neuronal cultures were isolated from 0- to 1-day-
old WT and EP1−/− pups, cultured in serum-free Neurobasal
medium supplemented with GlutaMax (Life Technologies, Grand
Island, NY), and NeuroCult SM1 (STEMCELL Technologies,
Vancover, BC) and plated onto poly-D-lysine-coated 24-well
plates at a density of 5 × 105 cells/well. Cells were maintained
in growth medium at 37◦C in 95% air/5% CO2-humidified
incubator for 10–12 days in vitro before treatment. Fifty per-
cent of the media was exchanged with fresh medium contain-
ing B27 (Life Technologies, Grand Island, NY) every 4 days.
Neurons from WT and EP1−/− pups were treated with either
vehicle control or hemin (Frontier Scientific, Logan, UT) in
Neurobasal/B27minus antioxidant supplemented medium. For
direct comparison between WT and EP1−/− neuronal cultures,
“sister cultures” were used to increase the reliability of our data.
ABSOLUTE QUANTITATIVE REAL-TIME PCR (qRT-PCR)
DNA vectors (pANT7_cGST, from DNASU) containing inserts
for each receptor (EP1-4) were cultured overnight in Luria-
Bertani broth/Amp (100μg/mL) at 37◦C. PlasmidDNAwas puri-
fied with a QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA).
Purified bacterial plasmidDNAwas linearized through restriction
enzyme digestion using Nco1 (New England Biolabs, Ipswich,
MA, USA) using manufacturer protocols. Completion of plasmid
digestion was visualized through gel electrophoresis with ethid-
ium bromide staining. Linearized plasmid DNA was gel extracted
using the Qiagen gel extraction kit (Qiagen) following the man-
ufactures protocols and quantified via Nanodrop-1000 spec-
trophotometer (Thermo Scientific,Waltham,MA). To analyze the
copy number of each receptor, eight point standard curves rang-
ing from 4.0 × 107 to 4000 copies per μL was constructed using
linearized plasmid DNA obtained from each receptor. Finally, to
ascertain the best concentration of cDNA synthesized from the
RNA isolated from our neuronal cultures and determine copy
numbers, a six point standard curve was developed for all four
receptors ranging from 200 to 3.125 ng of total cDNA. The copy
numbers for each receptor type was estimated using the following
formula: number of copies/μL = 6.022 × 1023 (moles/mole) ×
DNA concentration (g/μL)/number of base pairs × 660 Dalton’s
(Godornes et al., 2007). From our neuronal cultures, total RNA
was isolated using the PureLink RNA Mini Kit as detailed in
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the manufacture’s manual (Life Technologies). One microgram
of total RNA was subjected to DNase I treatment and concen-
tration determined using the Nanodrop-1000 spectrophotometer
and A260/A280 ratio (1.8–2.1) recorded (Thermo Scientific).
One microgram of total RNA was reverse transcribed using the
High-Capacity cDNA reverse transcription cDNA kit as described
by the manufacturer’s protocol (Life Technologies). The follow-
ing mouse specific TaqMan Gene Expression Assays for EP1-4
was used: (assay ID no’s, Mm00443098_g1; Mm00436051_m1;
Mm01316856_m1; Mm00436053_m1) (Life Technologies). The
qRT-PCR amplification cycle was: 95◦C for 3min followed by
39 cycles of 95◦C for 10 s 60◦C for 30 s using the BioRad C1000
thermal cycler.
HEMIN NEUROTOXICITY EXPERIMENTS AND ASSESSMENT OF CELL
SURVIVAL
To assess hemin neurotoxicity, neurons were treated with control
(Neurobasal/B27minus antioxidant supplement medium con-
taining 0.05% 0.1M NaOH) and hemin at concentrations 0, 12.5,
25, 50, 75, and 100μM for 18 h. In separate sets of experiments,
neurons were pre-treated with EP1 receptor selective antago-
nist SC-51089 (10μM) (Cayman Chemical, Ann Arbor, MI)
and selective COX-2 inhibitor NS-398 (10μM) (Sigma-Aldrich)
and NMDAR antagonist MK801 (10μM) (Sigma-Aldrich, St.
Louis, MO), for 15min in Neurobasal/B27minus antioxidant
supplement media and then with these agents still present, neu-
rons were co-treated with vehicle or hemin (75μM) for 18 h.
Cell viability was assessed using the CytoScan™-Fluoro assay
(G-Biosciences, St. Louis, MO). This is a fluorometric assay
(excitation/emission 530/590 nm) for estimating cell cytotoxicity
based on the release of LDH from cells with damaged mem-
branes. The low LDH activity (background) in wells subjected
to medium exchange only was subtracted from all values to yield
the signal specific for the neurotoxic insult-mediated by hemin
as described by Koh and Choi (Koh and Choi, 1987). To assess
the number of live cells, the Calcein AM (Life Technologies)
assay was performed as instructed by the manufactured proto-
col. Briefly, following treatment, medium was removed, neurons
were gently rinsed once in 1× DPBS and 200μL of Calcein
AM (3μM) added to neurons for 1 h at 37◦C. Next, the wells
were gently rinsed twice with 1× DPBS and the fluorescence
from each well was measured using the FlexStation 3 microplate
reader (Molecular Devices) at excitation/emission 485/530 nm.
Micrographs of neurons were acquired using a 20×DIC objective
on a Leica DMI6000 B monochrome digital camera and cap-
tured using the MetaMorph software (Molecular Devices LLC,
Sunnyvale, CA).
CALCIUM IMAGING
Eight to ten-day-old postnatal mouse cortical neuronal cul-
tures were loaded with 3μM Quest Fluo-8™ (Fluo-8 AM) (ATT
Bioquest, Inc, Sunnyvale, CA) in Hanks’ balanced salt solution
(HBSS) without CaCl2 andMgCl2 (Life Technologies) for 1 h and
washed twice with HBSS consisting of 2mM CaCl2 and 1mM
MgCl2. The membrane-permeable fluorescent calcium indicator
Fluo-8 AM was used for imaging dynamic changes in [Ca2+]i, an
increase in fluorescence intensity of Fluo-8 AM corresponds to
an increase in [Ca2+]i. To determine if the change in fluorescence
following treatment with hemin reached plateau, calibration of
Fluo-8 AMwas performed with NMDA (100μM) and ionomycin
(5μM) after the addition of hemin in the same cultures. Changes
in Fluo-8 AM-fluorescence intensity were measured following
addition of 17-pt-PGE2 (100 nM and 1μM) (Cayman Chemical,
Ann Arbor, MI) or hemin (1–25μM) for 60 s with and without
15min pre-treatment with SC-51089 (10μM), NS-398 (10μM),
MK-801 (10μM), nifedepine (10μM), ryanodine (50μM) and
vehicle (0.05% DMSO). The intensity of fluorescence was deter-
mined with excitation 482 nm and emission 505–530 nm of
selected neurons using a Leica DMI6000 B inverted microscope
equipped with Leica HC PL FLUOTAR 20×/0.50 objective and
LambdaDG-5 Plus. All images were captured using a Hamamatsu
electron multiplying charged-coupled device camera and select
regions acquired at a scanning time of ∼1 s per frame. A time
course of changes in fluorescence intensity generated was with
MetaFluor Fluorescence imaging software (Molecular Devices,
LLC). Fluo-8 AM fluorescence values are presented as F/F0
where F = F − F0, F is the fluorescence recorded following
17-pt-PGE2 or hemin application and F0 is the mean basal flu-
orescence. To determine statistical analysis between treatments,
area under the curve (AUC) was calculated for each neuron
recorded using the trapezoid rule as computed by GraphPad
Prism. Data for each treatment was from 3 to 6 independent
neuronal cultures. All imaging experiments were done at room
temperature.
STATISTICS
One-Way ANOVA was used to test for differences in mean val-
ues from multiple samples (LDH and Calcein AM assays and
calcium imaging data) with Bonferroni’s multiple comparison
tests. Statistical difference between two means was analyzed by
two-tailed unpaired or paired Student’s t-test. Differences were
considered significant if p < 0.05. All data are expressed as
mean ± SEM. All data were analyzed by GraphPad Prism 6.0
software.
RESULTS
NEURONAL CULTURES EXPRESS PGE2 EP1–4 RECEPTORS
Due to the lack of selectivity of antibodies against the EP1-4
receptors, we measured basal mRNA levels in our postnatal cor-
tical neuronal cultures. All four EP receptors are expressed at the
mRNA level in our neuronal cultures. Using absolute qRT-PCR
with gene-specific TaqMan assays we calculated the copy numbers
of each PGE2 receptor subtype. EP3 (estimated 40,000 copies)
is the most highly expressed receptor. The mRNA expression of
EP1, EP2, and EP4 receptors all had the same levels of expression
(estimated 4000 copies) (Figure 1).
KNOCKOUT AND BLOCKADE OF EP1 RECEPTOR IS PROTECTIVE
AGAINST HEMIN NEUROTOXICITY
Using neuronal cultures derived from WT and EP1−/− mouse
pups, hemin dose-response experiments were performed. In
neurons from WT pups, hemin caused significant neurotoxic-
ity as measured using the CytoScan-Fluoro LDH assay. LDH
levels released by 50μM (25.0 ± 2.2%), 75μM (34.7 ± 4.5%),
Frontiers in Molecular Neuroscience www.frontiersin.org October 2013 | Volume 6 | Article 31 | 3
Mohan et al. PGE2-EP1 receptor hemin toxicity
and 100μM (50.1 ± 4.2%) of hemin were significantly greater
compared to control (16.5 ± 1.5%). Using the LDH assay, we also
found hemin to be neurotoxic in neurons cultured from EP1−/−
mice. Hemin at 75μM (27.6 ± 3.3%) and 100μM (44.3 ±
0.8%) significantly increased LDH release as compared to con-
trol (12.8 ± 1.7) (Figure 2A). However, the percentage of LDH
released in response to hemin (50 and 75μM) was significantly
FIGURE 1 | PGE2 EP1-4 receptors are expressed in cultured cortical
neurons. Absolute qRT-PCR was performed using mouse-specific TaqMan
assays to measure basal expression of EP1-4 receptors in postnatal
neuronal cultures. The expression of the receptors EP1 through EP4 mRNA
is presented as estimated DNA copies using linearized plasmid standards
for each PGE2 receptor. Data represents mean ± SEM of triplicate
measures from four neuronal cultures. Statistical analysis was carried out
using One-Way ANOVA, with Bonferroni’s multiple comparison tests.
∗∗∗p < 0.001.
less in EP1−/− neurons compared to WT neurons. In separate
experiments, WT neurons were pre-treated with NMDAR antag-
onist, MK-801 (10μM) or EP1 receptor antagonist SC-51089
(10μM) for 15min and then co-treated with hemin (75μM).
Compared to hemin alone (61.8 ± 1.9%), MK-801 and SC-51089
significantly decreased (38.6 ± 10.4% and 42.7 ± 2.8%, respec-
tively) hemin-induced LDH release (Figure 2C). Similarly, treat-
ment with the COX-2 selective antagonist NS-398 significantly
decreased hemin-induced LDH release. This data suggests that
EP1 receptor, and its upstream COX-2 signaling pathways as well
as NMDAR are involved in hemin neurotoxicity.
In addition to measuring the LDH content, Calcein AM assay
was performed to measure the number of live cells. In sepa-
rate cohort of neuronal cultures, hemin dose-dependently also
decreased the number of live neurons; however the number
of live neurons was greater in EP1−/− neurons as compared
to WT neuronal cultures when treated with 50 and 75μM of
hemin (Figure 3A). In addition to decreasing hemin-induced
LDH release, treatment with SC-51089 also reduced the num-
ber of dead cells after hemin treatment. Compared to hemin
alone (43.1 ± 6.6%), the number of Calcein AM positive live
neurons increased (71.4 ± 10.7%) following treatment with SC-
51089. Similarly, following treatment with NS-398 and MK-801,
the number of live neurons significantly increased compared to
hemin treatment alone (Figure 3C). In addition, hemin induced a
change in the appearance of neurons fromWT and EP1−/− mice
as compared to control (Figures 2B, 3B). Representative images
show changes in hemin-induced Calcein AM fluorescence (live
cells) and diamidino-2-phenylindole (DAPI) staining in WT and
EP1−/− neuronal cultures (Figure 3B).
FIGURE 2 | EP1 receptor blockade and knockout reduces hemin
neurotoxicity. Primary postnatal neurons from WT and EP1−/− pups
cultured in serum-free Neurobasal media were treated with hemin
(12.5–100μM) for 18 h. (A) Hemin-induced cell viability was measured by
LDH assay [LDH/LDHMax %] from WT and EP1−/− neurons. ∗∗∗p < 0.001
vs. control; #p < 0.01 and ##p < 0.001 compared to the effect of hemin
(50 and 75μM) in neurons cultured from EP1−/− pups. (B) Cultured WT
and EP1−/− neurons were treated with vehicle control or hemin (50 and
75μM) for 18 h and phase-contrast images were captured using a 20×
DIC objective. (C) Cultured WT neurons were pre-treated with EP1
receptor antagonist, SC51089 (10μM), COX-2 antagonist, NS-398 (10μM)
and NMDAR antagonist, MK-801 (10μM) for 15min and were then
co-treated with hemin (75μM). After 18 h of treatment, cell viability was
measured using LDH assay. LDH assay data represent means ± SEM of
duplicate measures from triplicate wells from four to five experiments.
Statistical analysis was carried out using One-Way ANOVA, with
Bonferroni’s multiple comparison tests. ∗∗∗p < 0.001 vs. control; ∗p < 0.05
vs. hemin alone.
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FIGURE 3 | EP1 receptor blockade increased neuronal survival following
hemin treatment. Primary postnatal neurons from WT and EP1−/− pups
cultured in serum-free Neurobasal media were treated with hemin
(12.5–100μM) for 18 h. (A) Neuronal survival following hemin treatment was
measured by Calcein AM assay (% of control) from WT and EP1−/− neurons.
∗∗∗p < 0.001, ∗∗p < 0.01 and ∗p < 0.05 vs. control. (B) Cultured WT and
EP1−/− neurons were treated with vehicle control or hemin (75μM) for 18 h
and phase contrast and fluorescence images were captured with a 20X
phase-contrast images using a 20× DIC objective. (C) Cultured WT neurons
were pre-treated with SC51089 (10μM), NS-398 (10μM) and MK-801 (10μM)
for 15min and then co-treated with hemin (75μM). After 18 h of treatment,
live cells were measured using the Calcein AM assay. Calcein AM assay data
represent means ± SEM of duplicate measures from triplicate wells from
four experiments. Statistical analysis was carried out using One-Way ANOVA,
with Bonferroni’s multiple comparison tests. ∗∗∗p < 0.001 vs. control;
∗∗p < 0.01 and ∗p < 0.05 vs. hemin alone.
EP1 RECEPTOR-MEDIATED [Ca2+]i
The mechanism responsible for hemin neurotoxicity is not well
understood. Glutamate excitotoxicity, a process that involves
Ca2+ overload is suggested to be responsible for neuronal death
following hemin treatment. Thus, as an alternative mecha-
nism, we investigated EP1 receptor-associated [Ca2+]i in cortical
neurons. Treatment with 17-pt-PGE2 (100 nM and 1μM) sig-
nificantly increased [Ca2+]i (AUC: 100 nM—7.9; 1μM—18.8)
(Figure 4A). Next, 17-pt-PGE2-induced [Ca2+]i was compared
between WT and EP1−/− neuronal cultures. The mean AUC fol-
lowing application of 17-pt-PGE2 (1μM) was significantly differ-
ent betweenWT and EP1−/− neurons (18.8 vs. 12.4 respectively).
(p < 0.01, unpaired Student’s t-test) (Figure 4B).
In addition to studying [Ca2+]i in EP1−/− neurons, separate
experiments were conducted in WT neurons using SC-51089.
Pre-treatment with SC-51089 (10μM) reduced 17-pt-PGE2
(100 nM)-mediated [Ca2+]i (AUC: 5.1 for 17-pt-PGE2 alone vs.
2.4 with SC-51089) (Figure 5A). Further, the effect of inhibit-
ing the upstream COX-2 with NS-398 (10μM) on [Ca2+]i was
studied using 17-pt-PGE2 (100 nM). In these experiments, NS-
398 attenuated 17-pt-PGE2-mediated increase in [Ca2+]i (AUC:
5.1 for 17-pt-PGE2 alone vs. 1.5 with NS-398) (Figure 5B). To
determine the source of 17-pt-PGE2-induced [Ca2+]i, neuronal
cultures were pre-treated with MK-801 (10μM), L-type calcium
channel blocker, nifedepine (10μM) and ryanodine receptor
(RyR) antagonist, ryanodine (50μM). In all cases, application of
the antagonists lead to a significant decrease of the 17-pt-PGE2-
mediated [Ca2+]i (Figures 5C–E). Application of all used antago-
nists alone induced small changes in [Ca2+]i as compared to their
respective baseline values. The 17-pt-PGE2-mediated change in
[Ca2+]i in the presence of NS-398 and ryanodine was not signif-
icantly different from the values in response to these antagonist
alone. However, the 17-pt-PGE2-mediated change in [Ca2+]i in
the presence of MK-801 and nifedepine was significantly dif-
ferent from the values in response to these antagonist alone
(p < 0.05, One-Way ANOVAwith Bonferroni’s multiple compar-
ison tests). Following nifedepine treatment alone the measured
[Ca2+]i slightly but significantly decreased, the AUC has a nega-
tive value (−3.4) compared to that when the same antagonist was
used with 17-pt-PGE2 (AUC: 0.38). This decrease in [Ca2+]i by
nifedepine treatment alone may have been due to the steady-state
blockade of calcium influx via the L-type calcium channel.
HEMIN-INDUCED CHANGES [Ca2+]i IS EP1 AND RyR-MEDIATED
Previous reports suggest that iron neurotoxicity is mainly due
to glutamate excitotoxicity (Munoz et al., 2011; Im et al.,
2012). Hemin is an iron containing compound and iron
is a direct product of hemin degradation and therefore we
measured hemin-mediated changes in [Ca2+]i. Thus, follow-
ing application of hemin (1–25μM) for 60 s, we measured
a dose-dependent increase in [Ca2+]i and AUC in WT neu-
ronal cultures (Figure 6A). Similar experiments in neuronal
cultures from EP1−/− mice resulted in a significant decrease
in [Ca2+]i compared to WT neuronal cultures. Pseudocolor
microphotographs show changes in fluorescence in representa-
tive neurons before and after hemin treatment in WT neurons.
The plot represents the relationship between extracellular con-
centrations of hemin and [Ca2+]i in WT and EP1−/− neurons.
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FIGURE 4 | EP1 receptor mediated changes in [Ca2+]i in neurons.
(A) F/F0 values recorded in response to 17-pt-PGE2 (100 nM and 1μM)
normalized to the fluorescence values recorded before application of
17-pt-PGE2 and plotted as a function of time. Bar charts represent changes
in AUC (arbitrary units) following treatment with 17-pt-PGE2. (B) F/F0
values recorded in response to 17-pt-PGE2 (1μM) in neurons cultured from
WT and EP1−/− pups. Data represent mean ± SEM. Statistical analysis
was carried out using unpaired students t-test ∗∗∗p < 0.001 to compare the
change in fluorescence intensity between different two groups: 100 nM vs.
1μM; ∗∗p < 0.01 to compare between genotypes WT vs. EP1−/− in
response to 17-pt-PGE2.
A hemin mediated increase in [Ca2+]i in WT neurons was
significantly different from that measured in EP1−/− neurons
(Figure 6A). Hemin treatment at 3, 12.5 and 25μM in EP1−/−
neurons resulted in a significant decrease in the AUC than the
AUC measured in WT neurons at the same concentrations of
hemin. For example, at 12.5μM hemin, the AUC in WT neu-
rons was 13.13 and in EP1−/− neurons it was 3.14 (p < 0.05).
Using antagonists of the EP1 receptor, NMDAR and RyR, we
found that hemin-induced [Ca2+]i decreased. Treatment with
SC-51089 (10μM) (AUC: hemin 8.09 vs. SC-51089 0.90), MK-
801 (10μM) (AUC: 1.96), or ryanodine (50μM) (AUC: 1.1)
significantly decreased or abolished hemin-induced increase in
[Ca2+]i. However, treatment with nifedepine (10μM) (AUC: 3.8)
only decreased hemin-induced [Ca2+]i to 64.1 ± 16.6% of the
average value following hemin only (Figure 6B). Altogether, these
data suggest that in addition to the over activation of NMDAR’s,
hemin-induced neurotoxicity is mediated at least in part by the
over-activation of the EP1 receptor.
DISCUSSION
Prostaglandin-mediated inflammation and the accumulation of
red blood cell metabolites such as iron and hemin have been rec-
ognized in the pathogenesis of stroke, Alzheimer and Parkinson
diseases. However, our knowledge of how prostaglandins and
hemin accumulation results in neuronal death is unclear. The
results presented here show that hemin is neurotoxic and also
FIGURE 5 | Characterization of EP1 receptor mediated changes in
[Ca2+]i in neurons. In a separate set of neuronal cultures, neurons were
pre-treated with SC-51089 (10μM), NS-398 (10μM), MK-801 (10μM),
nifedepine (10μM), ryanodine (50μM) or vehicle control before 17-pt-PGE2
(100 nM) application and fluorescence intensity was recorded. Bars above
graphs indicate application time of 17-pt-PGE2 and antagonists/vehicle
control. (A–E) F/F0 and changes in AUC induced by 17-pt-PGE2 alone and
following pre-treatment with (A) SC-51089, (B) NS-398, (C) MK-801, (D)
nifedepine, and (E) ryanodine. Data represent mean ± SEM. Statistical
analysis was carried out using One-Way ANOVA with Bonferroni’s multiple
comparison tests. ∗∗∗p < 0.001 for17-pt-PGE2 alone or 17-pt-PGE2 plus
antagonist. ∗∗p < 0.01 and ∗p < 0.05 for 17-pt-PGE2 plus antagonist vs.
antagonist alone; ns, not significant.
affects Ca2+ signaling in neurons. We showed that hemin dose-
dependently increased the release of LDH from neurons and this
effect was significantly smaller in neurons cultured from EP1−/−
mice. Also, we showed that 17-pt-PGE2-mediated Ca2+ signal-
ing in EP1−/− neurons was significantly less than compared to
that in WT neurons, however; the increase in Ca2+ signaling
was still evident in EP1−/− neurons. Agonist 17-pt-PGE2 is a
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FIGURE 6 | Hemin mediated changes in [Ca2+]i in neurons.
(A) F/F0 induced by hemin (1, 3, 12.5, and 25μM) in WT
neurons. Plot represents relationship between extracellular
concentration of hemin and [Ca2+]i in WT and EP1−/− neurons.
Sequential pseudo color images of representative neurons shows
changes in [Ca2+]i in response to hemin (3 and 12.5μM) measured
using Fluo-8 AM (baseline and hemin for 60 s) in WT neurons.
#p < 0.01; ##p < 0.01 compared to the effect of hemin (3, 12.5, and
25μM) in neurons cultured from WT and EP1−/− mice. (B) F/F0
induced by hemin (12.5μM) alone and following pre-treatment with
SC-51089 (10μM), MK801 (10μM), nifedepine (10μM), and ryanodine
(50μM). Changes in AUC show that hemin-induced changes in
[Ca2+]i can be reduced by SC-51089, MK-801, nifedepine, and
ryanodine. Data represent mean ± SEM. Statistical analysis was
carried out using One-Way ANOVA, with Bonferroni’s multiple
comparison tests. ∗∗∗p < 0.001 vs. hemin alone.
synthetic analog of PGE2 and is often used as a selective EP1
receptor agonist (murine pki = 7.9). However, 17-pt-PGE2 also
shows considerable EP3 receptor (Gαq-protein - Ca2+ signaling)
agonism at higher concentrations and therefore may explain why
there was still Ca2+ signaling in EP1−/− neurons following treat-
ment with 17-pt-PGE2 (Okada et al., 2000). Future experiments
would include using even a more selective EP1 receptor agonist
when commercially available. Also, we showed that in mouse
neuronal cultures, the DNA copy of the EP3 receptor is greater
than that of the EP1 receptor. However, estimating copies of DNA
for each receptor type alone does not allow us to speculate the
impact this may have on the function of these receptors in vitro.
Further, if available in the future, experiments with improved
commercially available antibodies (greater selectivity) against the
EP1 receptor would allow us to determine the functional impli-
cations of higher levels of the EP3 receptor compared to that of
the EP1 receptor in vitro. Together with cell viability and Ca2+
imaging experiments, we showed that SC-51089 andMK-801 sig-
nificantly reduced hemin-induced neurotoxicity suggesting that
activation of NMDAR and EP1 receptors are involved in hemin-
induced neurotoxicity. Calcium imaging studies presented here
also indicate that hemin stimulates RyR-operated Ca2+ release as
the blockade of RyR resulted in the decrease of hemin-induced
[Ca2+]i in WT neurons.
Previous reports have suggested that prostaglandins
and their cognate receptors are involved in mechanisms of
neurodegeneration in cerebral ischemia and excitotoxic brain
injury (Doré, 2006; Serrano et al., 2011). When activated,
EP1 receptor couples to Gαq-proteins, resulting in increased
phosphatidyl inositol hydrolysis and the elevation of [Ca2+]i.
The increase in [Ca2+]i has an important role in the control
of neuronal function and plasticity (Catterall et al., 2013).
However, over-activation of EP1 receptors may also generate
supraphysiological changes in [Ca2+]i that exacerbate neuronal
cell death (Kawano et al., 2006). Due to the increased [Ca2+]i,
pharmacologic blockade of EP1 receptor could be a promising
therapeutic intervention against neuronal injury (Gendron et al.,
2005). We and others have shown that when the EP1 receptor is
blocked or ablated the neuronal damage and outcomes following
ischemic stroke are improved (Ahmad et al., 2006a; Kawano
et al., 2006; Saleem et al., 2007; Besancon et al., 2008; Abe et al.,
2009; Zhen et al., 2011). Recently, it was also found that the
death of cortical neurons induced by hypoxia was enhanced by
activation of EP1 receptors in vitro (Liu et al., 2012). The role of
[Ca2+]i in neuronal activity and excitotoxicity following hemor-
rhage is unknown; however, data suggest that increased [Ca2+]i
contributes to increased cerebral vasospasm commonly seen in
intracerebral hemorrhage (Kikkawa et al., 2010; Koide et al.,
2011). However, protection of the brain against intracerebral
hemorrhage following the blockade of the EP1 receptor may be
complicated by the expression and signaling of the EP1 receptor
in different cell types. For example, microglia cultured from
EP1−/− mice showed reduced neuroprotection when treated
with NMDA in neuron-glia co-cultures (Carlson et al., 2009).
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Even though our in vitro data demonstrates that EP1 dele-
tion provides neuroprotection against hemin-induced cell death,
recently our group has found that EP1 deletion may exac-
erbate neurobehavioral impairments in a collagenase-induced
mouse model of hemorrhagic stroke by impairing the function of
microglial cells surrounding the area of injury (Singh et al., 2013).
The differences in the function of the EP1 receptors between
in vitro and in vivo models are so numerous that different cell
types that express the EP1 receptor may reflect the overall out-
comes. Although the hemin-mediated increase in [Ca2+]i was
significantly different between WT and EP1−/− neuronal cul-
tures, the EP1 receptor pathway may not be the single excitotoxic
pathways activated by hemin.
The overactivation of postsynaptic glutamate receptors and the
neuronal loading of Na+ and Ca2+ results in the rapid deple-
tion of neuronal energy, with a significant reduction in adenosine
triphosphate (Tsuji et al., 1994; Atlante et al., 1996). Similarly,
neuronal cell death in preclinical models of stroke has also been
linked to NMDAR overactivation (Besancon et al., 2008). The
increase in transient levels of extracellular glutamate has been
postulated to trigger rapidly evolving free radical production
through the activation of Ca2+-permeable NMDARs (Lafon-
Cazal et al., 1993; Reynolds andHastings, 1995; Thiex et al., 2007).
Also, the activation of synaptic or extrasynaptic NMDARs has
been reported to be neuroprotective or excitotoxic, respectively
(Hardingham et al., 2002; Stark and Bazan, 2011). Interestingly,
Bazan’s group also suggested that cell death following stimula-
tion of extrasynaptic NMDARs is due to the induction of COX-2
signaling from a physiological to a potentially pathological pro-
cess. In an separate earlier study, activation of the EP1 receptor
was found to disrupt Ca2+ homeostasis with NMDA treatment
by impairing the function of Na+/Ca2+ exchanger mechanisms
(Kawano et al., 2006). To demonstrate the role of NMDARs in
hemin neurotoxicity, we used the NMDAR antagonist MK-801,
and found that it significantly reduced hemin neurotoxicity and
hemin-mediated increase in [Ca2+]i. The measured decrease in
hemin neurotoxicity and [Ca2+]i after blockade of NMDARs sug-
gests that NMDAR activation is also involved and perhaps more
so during the initial phases of hemin-induced [Ca2+]i in neu-
rons. Interestingly, our data also show that the hemin-induced
increase in [Ca2+]i was partially decreased with nifedepine, a
selective blocker of L-type Ca2+ channels. The involvement of
Ca2+ channels in hemin neurotoxicity is possibly due to presy-
naptic facilitation of glutamate release and consequent overac-
tivation of NMDARs. Considering the predominate effects of
hemin on NMDAR-mediated neuronal death, we postulate that
Ca2+ entry via postsynaptic and/or extrasynaptic NMDARs may
alter the neuronal excitability and cellular signaling resulting in a
deficit in overall neuronal networks.
Iron, as a neurotoxic breakdown product of heme and Hb, has
previously been shown to stimulate RyR and mediate an increase
in [Ca2+]i through its capacity to generate ROS (Munoz et al.,
2006; Hidalgo et al., 2007). Also in support, recent data showed
that blockade of L-type calcium channels protected hippocampal
neurons against iron neurotoxicity in vivo (Bostanci and Bagirici,
2013). Taken together (these facts and our experimental data),
we speculate that hemin may also stimulate RyR-mediated Ca2+
release through its capacity to generate ROS. In this study, fol-
lowing treatment with RyR antagonist, hemin-induced increase
in [Ca2+]i was abolished suggesting that RyR is involved in
the hemin-induced increase in [Ca2+]i following stimulation of
NMDARs. These data show that hemin-induced [Ca2+]i signaling
is rapidly initiated and is a lasting process that may have a role in
neuronal death.
In summary, we have demonstrated that pharmacologic block-
ade and genetic deletion of the EP1 receptor can affect the
outcome of hemin-induced cell death in cultured postnatal corti-
cal neurons. Our data suggest that hemin-induced neurotoxicity
is mediated by an abnormal increase in [Ca2+]i via activation
of multiple mutually dependent processes involving NMDARs,
L-type Ca2+ channels, and calcium-induced calcium release via
activation of intracellular RyR and COX-2 pathway. Also, the data
that 17-pt-PGE2 and hemin-mediated increase in [Ca2+]i were
inhibited by blockade of the EP1 receptor suggest involvement
of this receptor as an important counterpart in hemin-induced
toxicity.
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